179 related articles for article (PubMed ID: 23895135)
21. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
22. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary analysis of chromosome abnormalities in breast mammary phyllodes tumour by comparative genomic hybridization (CGH)].
Niu Y; Lü SH; Liu QJ; Wang XW; Chen Y; Ding XM
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):296-7. PubMed ID: 16777003
[No Abstract] [Full Text] [Related]
24. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract][Full Text] [Related]
25. Osteosarcomatous differentiation in lung metastases from a malignant phyllodes tumour of the breast.
Tsubochi H; Sato N; Kaimori M; Imai T
J Clin Pathol; 2004 Apr; 57(4):432-4. PubMed ID: 15047752
[TBL] [Abstract][Full Text] [Related]
26. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J; Xu Q; Liu D; Li X; Guo M; Chen X; Liao J; Lei R; Li W; Huang H; Saw PE; Song E; Yan X; Nie Y
Cancer Commun (Lond); 2023 Nov; 43(11):1244-1266. PubMed ID: 37856423
[TBL] [Abstract][Full Text] [Related]
27. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
28. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
29. Identification of molecular targets in vulvar cancers.
Palisoul ML; Mullen MM; Feldman R; Thaker PH
Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
Jones AM; Mitter R; Springall R; Graham T; Winter E; Gillett C; Hanby AM; Tomlinson IP; Sawyer EJ;
J Pathol; 2008 Apr; 214(5):533-44. PubMed ID: 18288784
[TBL] [Abstract][Full Text] [Related]
31. Egfr amplification specific gene expression in phyllodes tumours of the breast.
Agelopoulos K; Kersting C; Korsching E; Schmidt H; Kuijper A; August C; Wülfing P; Tio J; Boecker W; van Diest PJ; Brandt B; Buerger H
Cell Oncol; 2007; 29(6):443-51. PubMed ID: 18032821
[TBL] [Abstract][Full Text] [Related]
32. [A patient with pulmonary metastasis of phyllodes tumour of the breast].
Solberg OG; Blom GP; Stavem K
Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2956-7. PubMed ID: 16299881
[TBL] [Abstract][Full Text] [Related]
33. The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.
Przybytkowski E; Ferrario C; Basik M
BMC Med Genomics; 2011 Jan; 4():16. PubMed ID: 21272361
[TBL] [Abstract][Full Text] [Related]
34. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
[TBL] [Abstract][Full Text] [Related]
35. Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy.
Koukourakis IM; Zygogianni A; Kouloulias V; Koukourakis MI
Chemotherapy; 2021; 66(3):82-86. PubMed ID: 34233328
[TBL] [Abstract][Full Text] [Related]
36. Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
Mitus J; Adamczyk A; Majchrzyk K; Kowalik A; Ryś J; Niemiec J
Pol J Pathol; 2020; 71(1):7-12. PubMed ID: 32429649
[TBL] [Abstract][Full Text] [Related]
37. [Recent advances in molecular pathology of phyllodes tumor of breast].
Niu Y
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):135-7. PubMed ID: 21426820
[No Abstract] [Full Text] [Related]
38. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
[TBL] [Abstract][Full Text] [Related]
39. MED12 exon 2 mutations in phyllodes tumors of the breast.
Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
[TBL] [Abstract][Full Text] [Related]
40. Recent insights into the molecular pathogenesis of mammary phyllodes tumours.
Karim RZ; O'Toole SA; Scolyer RA; Cooper CL; Chan B; Selinger C; Yu B; Carmalt H; Mak C; Tse GM; Tan PH; Putti TC; Lee CS
J Clin Pathol; 2013 Jun; 66(6):496-505. PubMed ID: 23404800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
